Home/ Supplements/ Calcium/ Cipcal-500

Cipcal-500

product on market Tablet or Pill Cipla Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Calcium carbonate and cholecalciferol are used to support bone density and mineral metabolism. There is strong clinical evidence that this combination helps prevent bone loss and osteoporosis. The ingredients are generally well-tolerated and maintain a high safety profile.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Cipcal-500
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
Single Vitamin and Mineral
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

1.25 Gram(s)
Market median: 500.0mg (266 products) 441 studies (A:25, B:228)
Within RDA (0.4× RDA) 608 studies (A:16, B:251)

Other Ingredients

Titanium Dioxide IP
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Info

Product Information

Directions for Use

Dosage: As directed by the physician

Warnings & Precautions

Keep out of reach of children.

Formulation Notes

Calcium with Vitamin D3 tablets

Additional Information

Store below 25 degrees C. Protected from light and moisture.

20 x 15 Tablets

M.L. 51/UA/SC/P-2013

Metadata

Product Details

DSLD Entry Date2020-11-21
Product TypeSingle Vitamin and Mineral
FormTablet or Pill
BrandCipla
DSLD ID239420
Data Updated2026-04-11
Research

Research Evidence

511
Research Sources
57
Avg Quality
266
Meta Analysis
95
Systematic Review
76
Rct
49
Clinical Trial
12
Guideline
4
Regulatory Source
2
Cochrane Review
2
Other
2
Narrative Review
1
Openfda Safety
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A First-line drugs for hypertension
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Beta-blockers for hypertension
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Calcium →
Compare

Similar Products

View all Calcium products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.